We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rare Interstitial Pneumonia Due to the Use of Aripiprazol: A Case Report.
- Authors
Alpagat, Gulistan; Baccioglu, Ayse; Yalim, Sumeyra Alan; Poyraz, Merve; Dumanoglu, Betul; Kalpaklioglu, Ayse Fusun
- Abstract
It is accepted that 2-3% of interstitial lung diseases (ILD) are due to drugs, and that 70% of drug-induced lung diseases are due to ILD. We present here the case of a 51-year-old female patient who had been taking aripiprazole for bipolar disorder for 3 years and had been undergoing asthma treatment for 2 years. ILD was considered based on the patient's clinic, a restrictive pattern in the pulmonary function test (PFT), a decreased carbon monoxide diffusion test, laboratory results, radiological findings and biopsy. The possible etiologies of infection, aspiration, heart failure, pet feeding status and exposure to hazardous respiratory substances were excluded. The suspected drug was discontinued and oral corticosteroid treatment was started. Lung toxicity can develop with drug treatments, and so drug history should be questioned in detail and discontinued immediately in case of any doubt. ILD is rare, and if the drug is not suspected and continued, the disease may become chronic and progress to respiratory failure. We present this case to increase awareness of the disease.
- Subjects
HAZARDOUS substance exposure; INTERSTITIAL lung diseases; PULMONARY function tests; PULMONARY fibrosis; LUNG diseases; RESPIRATORY insufficiency
- Publication
Respiratory Case Reports, 2022, Vol 11, Issue 1, p44
- ISSN
2147-2475
- Publication type
Article
- DOI
10.5505/respircase.2022.80948